ID   NAA10_MOUSE             Reviewed;         235 AA.
AC   Q9QY36;
DT   10-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   04-FEB-2015, entry version 109.
DE   RecName: Full=N-alpha-acetyltransferase 10;
DE            EC=2.3.1.-;
DE            EC=2.3.1.88;
DE   AltName: Full=N-terminal acetyltransferase complex ARD1 subunit homolog A;
DE   AltName: Full=NatA catalytic subunit Naa10;
GN   Name=Naa10; Synonyms=Ard1, Ard1a, Te2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND INTERACTION WITH HIF1A.
RC   TISSUE=Embryo, and T-cell;
RX   PubMed=12464182; DOI=10.1016/S0092-8674(02)01085-1;
RA   Jeong J.-W., Bae M.-K., Ahn M.-Y., Kim S.-H., Sohn T.-K., Bae M.-H.,
RA   Yoo M.-A., Song E.-J., Lee K.-J., Kim K.-W.;
RT   "Regulation and destabilization of HIF-1alpha by ARD1-mediated
RT   acetylation.";
RL   Cell 111:709-720(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH NAA15,
RP   SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=12888564; DOI=10.1074/jbc.M301218200;
RA   Sugiura N., Adams S.M., Corriveau R.A.;
RT   "An evolutionarily conserved N-terminal acetyltransferase complex
RT   associated with neuronal development.";
RL   J. Biol. Chem. 278:40113-40120(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Platzer M., Brenner V., Reichwald K., Wiehe T., Oksche A.,
RA   Rosenthal A.;
RT   "Comparative sequence analysis of the mouse L1cam locus and the
RT   corresponding region of human Xq28.";
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Embryonic liver;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
CC   -!- FUNCTION: Catalytic subunit of the N-terminal acetyltransferase A
CC       (NatC) complex which displays alpha (N-terminal) acetyltransferase
CC       activity. Without NAA15, displays epsilon (internal)
CC       acetyltransferase activity towards HIF1A, thereby promoting its
CC       degradation. Represses MYLK kinase activity by acetylation, and
CC       thus represses tumor cell migration. Acetylates, and stabilizes
CC       TSC2, thereby repressing mTOR activity and suppressing cancer
CC       development (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + peptide = N(alpha)-acetylpeptide
CC       + CoA.
CC   -!- SUBUNIT: Component of the N-terminal acetyltransferase A (NatA)
CC       complex composed of NAA10 and NAA15 or NAA16. Interacts with the
CC       ribosome. Binds to MYLK. Associates with HYPK when in complex with
CC       NAA15 (By similarity). Interacts with HIF1A and NAA50. Interacts
CC       (via its C-terminal domain) with TSC2, leading to its acetylation
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12888564}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:12888564}.
CC   -!- DEVELOPMENTAL STAGE: Expressed throughout the developing brain
CC       from E11.5 through E17, continues to be expressed at P0, but then
CC       is down-regulated. {ECO:0000269|PubMed:12888564}.
CC   -!- PTM: Cleaved by caspases during apoptosis. {ECO:0000250}.
CC   -!- PTM: Phosphorylation by IKBKB/IKKB at Ser-209 destabilises NAA10
CC       and promotes its proteasome-mediated degradation.
CC   -!- SIMILARITY: Belongs to the acetyltransferase family. ARD1
CC       subfamily. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 N-acetyltransferase domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00532}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK014469; BAB29373.1; -; mRNA.
DR   EMBL; AF133093; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS30217.1; -.
DR   RefSeq; NP_063923.1; NM_019870.3.
DR   UniGene; Mm.246654; -.
DR   ProteinModelPortal; Q9QY36; -.
DR   SMR; Q9QY36; 1-152.
DR   BioGrid; 207880; 8.
DR   IntAct; Q9QY36; 7.
DR   STRING; 10090.ENSMUSP00000033763; -.
DR   PhosphoSite; Q9QY36; -.
DR   MaxQB; Q9QY36; -.
DR   PaxDb; Q9QY36; -.
DR   PRIDE; Q9QY36; -.
DR   Ensembl; ENSMUST00000033763; ENSMUSP00000033763; ENSMUSG00000031388.
DR   GeneID; 56292; -.
DR   KEGG; mmu:56292; -.
DR   UCSC; uc009tng.2; mouse.
DR   CTD; 8260; -.
DR   MGI; MGI:1915255; Naa10.
DR   eggNOG; COG0456; -.
DR   GeneTree; ENSGT00550000074803; -.
DR   HOGENOM; HOG000078523; -.
DR   HOVERGEN; HBG050561; -.
DR   InParanoid; Q9QY36; -.
DR   KO; K00670; -.
DR   OrthoDB; EOG7T4MMM; -.
DR   PhylomeDB; Q9QY36; -.
DR   TreeFam; TF300078; -.
DR   NextBio; 312200; -.
DR   PRO; PR:Q9QY36; -.
DR   Proteomes; UP000000589; Chromosome X.
DR   Bgee; Q9QY36; -.
DR   ExpressionAtlas; Q9QY36; baseline and differential.
DR   Genevestigator; Q9QY36; -.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0022626; C:cytosolic ribosome; IBA:GO_Central.
DR   GO; GO:0005622; C:intracellular; ISO:MGI.
DR   GO; GO:0016020; C:membrane; ISO:MGI.
DR   GO; GO:0031415; C:NatA complex; ISO:MGI.
DR   GO; GO:0005730; C:nucleolus; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0008080; F:N-acetyltransferase activity; IDA:MGI.
DR   GO; GO:1990190; F:peptide-glutamate-N-acetyltransferase activity; IBA:GO_Central.
DR   GO; GO:1990189; F:peptide-serine-N-acetyltransferase activity; IBA:GO_Central.
DR   GO; GO:0043022; F:ribosome binding; IEA:Ensembl.
DR   GO; GO:0006475; P:internal protein amino acid acetylation; IBA:GO_Central.
DR   GO; GO:0018002; P:N-terminal peptidyl-glutamic acid acetylation; IBA:GO_Central.
DR   GO; GO:0017198; P:N-terminal peptidyl-serine acetylation; IBA:GO_Central.
DR   GO; GO:0006474; P:N-terminal protein amino acid acetylation; ISO:MGI.
DR   Gene3D; 3.40.630.30; -; 1.
DR   InterPro; IPR016181; Acyl_CoA_acyltransferase.
DR   InterPro; IPR000182; GNAT_dom.
DR   Pfam; PF00583; Acetyltransf_1; 1.
DR   SUPFAM; SSF55729; SSF55729; 1.
DR   PROSITE; PS51186; GNAT; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Acyltransferase; Complete proteome; Cytoplasm;
KW   Phosphoprotein; Reference proteome; Transferase.
FT   CHAIN         1    235       N-alpha-acetyltransferase 10.
FT                                /FTId=PRO_0000074533.
FT   DOMAIN        1    152       N-acetyltransferase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00532}.
FT   REGION        1     58       Interaction with NAA15. {ECO:0000250}.
FT   MOD_RES       1      1       N-acetylmethionine. {ECO:0000250}.
FT   MOD_RES     205    205       Phosphoserine. {ECO:0000250}.
FT   MOD_RES     209    209       Phosphoserine; by IKKB. {ECO:0000250}.
FT   MOD_RES     213    213       Phosphoserine. {ECO:0000250}.
FT   MOD_RES     216    216       Phosphoserine. {ECO:0000250}.
SQ   SEQUENCE   235 AA;  26520 MW;  AD2991C519277F29 CRC64;
     MNIRNARPED LMNMQHCNLL CLPENYQMKY YFYHGLSWPQ LSYIAEDENG KIVGYVLAKM
     EEDPDDVPHG HITSLAVKRS HRRLGLAQKL MDQASRAMIE NFNAKYVSLH VRKSNRAALH
     LYSNTLNFQI SEVEPKYYAD GEDAYAMKRD LTQMADELRR HLELKEKGKH MVLAALENKA
     ENKGNVLLSS GEACREEKGL AAEDSGGDSK DLSEVSETTE STDVKDSSEA SDSAS
//
